Inactive Instrument

InterMune Inc Share Price

Stocks

End-of-day quote Nasdaq
- ^USD	-

16/09/14	CHUGAI PHARMACEUTICAL : Roche's $8 billion InterMune buy not a signal for more big deals	RE
04/09/14	Roche : rules out mega deals, open to smaller ones - paper	RE

16/09/14	CHUGAI PHARMACEUTICAL : Roche's $8 billion InterMune buy not a signal for more big deals	RE
04/09/14	Roche : rules out mega deals, open to smaller ones - paper	RE
27/08/14	Biogen Idec : InterMune drug may offer big upside to Roche if aimed at liver	RE
25/08/14	Burger King Worldwide : S&P 500 sets record high but fails to hold 2,000 mark	RE
25/08/14	CHUGAI PHARMACEUTICAL : Roche to buy U.S. biotech firm InterMune for $8.3 billion	RE
19/03/14	Horizon Pharma Inc : With eye on tax rates, Horizon Pharma buys Ireland's Vidara	RE
06/06/13	NVIDIA Corporation : SAC insider-trading probe could last years	RE
20/03/13	Weight Watchers International, Inc. : SAC Capital up 4 percent this year as probe continues	RE
16/03/13	Morgan Stanley : Cohen's SAC to pay $616 million in SEC insider trade settlement	RE
28/12/12	InterMune, Inc. : Blackstone seen sticking with SAC despite insider trading probe	RE
19/12/12	Weight Watchers International, Inc. : SAC Capital's top consumer trader draws U.S. scrutiny	RE
08/12/12	Elan Corporation, plc : Exclusive: U.S. authorities probe SAC for Weight Watchers - sources	RE
23/07/12	InterMune, Inc. : InterMune posts lower-than-expected revenue	RE

02/10/14	InterMune : Announces Effective Date of Make Whole Fundamental Change and Offer to Purchase to Holders of 2.50% Senior Convertible Notes Due 2018	PU
20/09/14	InterMune : Reports Memorandum of Understanding in Connection with Consolidated Delaware Action	PR
05/09/14	InterMune : Announces Anticipated Fundamental Change for 5.00% Convertible Senior Notes Due 2015	PR
27/08/14	InterMune : Stockholders Encouraged to Contact Securities Law Firm about Takeover	PR
26/08/14	InterMune : INVESTOR ALERT – InterMune, Inc.: The Law Offices of Vincent Wong Investigates the Sale of InterMune, Inc. to Roche Holding AG	BU

04/09/14	Roche : exclut une mega-fusion, ouvert à de plus petits rachats
25/08/14	Wall Street finit dans le vert, le S&P passe un cap
25/08/14	Burger King Worldwide : Wall Street ouvre en hausse sur un nouveau record du S&P
25/08/14	Wall Street ouvre en hausse avec les M&A et l'Europe
25/08/14	Apple : USA-Les valeurs à suivre à Wall Street

Manager	Title	Age	Since
Mark Thompson CEO	Chief Executive Officer	57	-
Marianne T. Armstrong CTO	Chief Tech/Sci/R&D Officer	71	31/03/2002
Carla Fiankan LAW	General Counsel	-	31/07/2011

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
WUXI APPTEC CO., LTD.	+1.52%	-7.19%	+51.66%	+69.99%	65B
LONZA GROUP AG	+1.52%	+6.83%	+10.77%	+79.30%	51.2B
ARGENX SE	+0.30%	-0.46%	+2.53%	+61.89%	51.19B
IQVIA HOLDINGS INC.	-0.38%	+1.40%	+29.98%	+42.37%	43.93B
BEONE MEDICINES AG	+0.30%	+5.64%	+16.99%	+133.30%	41.96B
REVOLUTION MEDICINES, INC.	+2.35%	-6.08%	+236.69%	+528.10%	38.14B
CELLTRION, INC.	+2.16%	+9.87%	+18.92%	+59.70%	33.24B
WUXI BIOLOGICS (CAYMAN) INC.	+3.49%	-2.75%	+38.60%	+8.11%	25.2B
GENMAB A/S	+1.60%	+2.21%	+21.34%	+28.00%	22.5B
Average	+1.42%	-0.04%	+47.50%	+112.31%	41.37B
Weighted average by Cap.	+1.26%	-0.16%	+46.13%	+113.32%

Employees

Sector